Insights
InsightsSubscribe
Insights
Aug. 13, 2020
Patentability Considerations for Antibody-Related Inventions
BioPharm International
Abstract
Rapid advancements in immunotherapies have made patents in this field more important than ever. The global market for antibody based drugs is expected to reach over USD $114 billion by 2022. At the same time, increased stringency of U.S. written description and patent eligibility requirements, as well as accumulated worldwide prior art, have restricted the ability to gain broad antibody coverage. This article discusses the different categories of antibody claims and related patentability challenges in the U.S. and major ex-U.S. markets. Statistics on issue rates and and post-grant proceedings for antibody patents also are reviewed.
MEET OUR AUTHORS
These materials have been prepared for informational purposes only and are not legal advice. This information is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Internet subscribers and online readers should not act upon this information without seeking professional counsel.